Form 3 - Initial statement of beneficial ownership of securities
26 Diciembre 2023 - 3:15PM
Edgar (US Regulatory)
Exhibit 24
SECTION 16 POWER OF ATTORNEY
With respect to holdings of and transactions in securities issued by
Inspire Medical Systems, Inc. (the “Company”), the undersigned hereby constitutes and appoints the officers of
the Company listed on Schedule A attached hereto and as may be amended from time to time, or any of them signing singly,
with full power of substitution and resubstitution, to act as the undersigned’s true and lawful attorney-in-fact to:
| 1. | execute for and on behalf of the undersigned, Forms 3, 4,
and 5 in accordance with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder; |
| 2. | do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments
thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority;
and |
| 3. | take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in the
discretion of such attorney-in-fact. |
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any
of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present,
with full power of substitution and resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-facts substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights
and powers herein granted.
The undersigned acknowledges that the attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor is any Company assuming, any of the undersigned’s responsibilities
to comply with Section 16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of the 20th of December, 2023.
|
/s/
Myriam J. Curet, M.D. |
|
Myriam J. Curet, M.D. |
Schedule A
Individuals Appointed as Attorney-in-Fact with Full Power
of Substitution and Resubstitution
1. Bryan Phillips |
Senior Vice President, General Counsel and Secretary, and Chief Compliance Officer |
2. Richard Buchholz |
Chief Financial Officer |
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024